Study type
Neurology studies recruiting now
Neurology research spans migraine, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy, stroke and nerve pain.
690 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
More recruiting studies (pay not posted)
- RecruitingPhase 2
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
ModernaTX, Inc.
- Location
- Farmington Hills, MI + 5 other US sites
- Eligibility basics
- Ages 18–55
- Recruiting
The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study
Luminate Medical, Inc.
- Location
- Norwich, CT + 15 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
Neurona Therapeutics
- Location
- Birmingham, AL + 34 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
Serina Therapeutics
- Location
- Hallandale, FL + 2 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 4
Two Dose Levels of Privigen in Pediatric CIDP
CSL Behring
- Location
- Philadelphia, PA + 2 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 1/Phase 2
Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)
Sangamo Therapeutics
- Location
- Scottsdale, AZ + 5 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Use of CereGate Therapy for Freezing of Gait in PD
CereGate Inc.
- Location
- Redwood City, CA + 6 other US sites
- Eligibility basics
- Ages 21–80
- Recruiting
Preventing Medication Mismanagement in People Living With Dementia
HiDO Technologies
- Location
- Folsom, CA
- Eligibility basics
- Ages 65+
- RecruitingPhase 2
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
AbbVie
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 1
Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
Life Biosciences Inc.
- Location
- Glendale, CA + 3 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingPhase 1/Phase 2
This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.
iRegene Therapeutics Co., Ltd.
- Location
- New York, NY
- Eligibility basics
- Ages 30–75
- RecruitingPhase 1/Phase 2
A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
Hoffmann-La Roche
- Location
- Boston, MA + 4 other US sites
- Eligibility basics
- Ages 25–65
- RecruitingPhase 2
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Takeda
- Location
- La Jolla, CA + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
Supernus Pharmaceuticals, Inc.
- Location
- Jacksonville, FL + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingPhase 1
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
Amylyx Pharmaceuticals Inc.
- Location
- La Jolla, CA + 9 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Paradromics
- Location
- Sacramento, CA + 2 other US sites
- Eligibility basics
- Ages 22–75
- Recruiting
PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss Due to Stroke, Traumatic Brain Injury, or Brain Surgery
NeuroAEye LLC
- Location
- Cedar Rapids, IA + 1 other US site
- Eligibility basics
- Ages 21–80
- Recruiting
Neuralert Stroke Monitor Trial
Neuralert Technologies LLC
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 22+
- Recruiting
NobleStitch EL STITCH Trial is a PFO Comparative Trial
Nobles Medical Technologies II Inc
- Location
- Tucson, AZ
- Eligibility basics
- Ages 18–60
- Recruiting
Advancement of Vestibular Intervention Via Portable Electrical Stimulator (VIPES)
Vivonics, Inc.
- Location
- Ann Arbor, MI
- Eligibility basics
- Ages 18–55
- RecruitingPhase 4
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Route 92 Medical, Inc.
- Location
- West Jordan, UT
- Eligibility basics
- Ages 18+
- Recruiting
Neurostimulation for the Treatment of Post-Stroke Aphasia
QVITI S.A.
- Location
- Chicago, IL + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
Open-label Extension Study in Participants With Early Alzheimer's Disease
GlaxoSmithKline
- Location
- Maitland, FL + 8 other US sites
- Eligibility basics
- Ages 50–85
- RecruitingPhase 1/Phase 2
Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms
U: The Mind Company
- Location
- Cleveland, OH
- Eligibility basics
- Ages 18–80
Who these studies look for
Most require a confirmed diagnosis; memory studies often ask for a study partner who knows you well to attend some visits.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.
Questions
Why do memory studies need a study partner?
A partner can report day-to-day changes the participant may not notice. Each study explains what the partner is asked to do.